Drug Testing: Technologies and Global Markets

  • ID: 4298800
  • Report
  • Region: Global
  • 135 Pages
  • BCC Research
15 % OFF
until Jun 30th 2018
1 of 6
The Global Drug of Abuse (DOA) Testing Market is Estimated to Grow at a CAGR of 4.5% to Reach Nearly $3.9 Billion by 2022 from $3.1 Billion in 2017

FEATURED COMPANIES

  • 1 Step Detect Associates
  • Alfa Scientific
  • Bioscan Screening Systems
  • Hoffmann-La Roche, Ltd.
  • Medtox Diagnostics
  • Polymed Therapeutics
  • MORE

Report Includes

  • An overview of the global market for drug testing technologies.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
  • Information on leading players in the market and their key products.
  • Analysis of leading companies in the field and their successful strategies.

Report Scope

This Report Contains:

  • An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
  • Drug abuse statistics in key regions.
  • Analysis of regulatory environments in North, South and Central America, Europe, and Asia-Pacific, and country-wise summaries of national legislation and policies.
  • Drug of abuse testing markets with respect to testing approaches and sample matrices.
  • Technology trends in the drug of abuse testing market.
  • Leading players in the market and their key products.
  • Sales projections through 2022 for drug of abuse testing markets by sample matrix and geographic regions.
  • Analysis of leading companies and their successful strategies.
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 1 Step Detect Associates
  • Alfa Scientific
  • Bioscan Screening Systems
  • Hoffmann-La Roche, Ltd.
  • Medtox Diagnostics
  • Polymed Therapeutics
  • MORE

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Intended Audience
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographic Breakdown

2: Summary and Highlights

  • Executive Summary

3: Market and Technology Background

  • Single- Vs. Multi-Parameter Test
  • DOA Screening
  • Confirmation Testing
  • Urine Tests
  • Other Testing Methods
  • Testing Locations
  • Point of Care DATS
  • Onsite Testing Vs Laboratory Testing
  • Sample Types for Laboratory Testing
  • Detection Period
  • Fooling a Drug Test
  • Sample Validity Tests
  • False Positives and False Negatives
  • Testing Technologies

4: Government Regulations: Drug Trafficking and Drug Abuse Testing

  • North America
  • South America
  • Central America and the Caribbean
  • Europe
  • Asia-Pacific

5: Overview of Drug Abuse Testing

  • Drug Abuse Testing
  • International Drug Trafficking and Illicit Drug Use Trends by Drug Type
  • International Drug Trafficking and Illicit Drug Use Trends by Geographic Region
  • Europe
  • Oceania
  • U.S. DOA Statistics

6: Global Drugs of Abuse Testing Market by Sample Type

  • DOA Testing Sales
  • Global Sales of DOA Testing by Urine
  • Global Sales of DOA Testing by Blood
  • Global Sales of DOA Testing by Oral Fluid
  • Global Sales of DOA Testing by Hair
  • Global Sales of DOA Testing by Sweat
  • Global Sales of DOA Testing by Other Sample Types

7: Global Industry Structure

  • Regional Analysis
  • Total DOA Testing and Drug Monitoring Markets and Forecasts
  • Competitive Analysis
  • Laboratory-based DOA Testing Market Segment
  • Onsite Testing Market Segment for DOA
  • Common DOA and Most Popular Devices Used for Testing Them
  • Companies in the Oral Fluid, Hair and Sweat Testing Segments for DOA

8: Patent Analysis

  • Table 45 : Selected U.S. Patents Granted for DOA Testing, 2007-2017

9: Company Profiles

  • 1 Step Detect Associates
  • Abbott Diagnostics
  • Accutech
  • Acon Laboratories
  • Agilent Technologies
  • Alere
  • Alfa Scientific
  • American Bio Medica
  • Atlas Link Biotech
  • Beckman Coulter
  • Biophor Diagnostics
  • Bio-Rad Laboratories
  • Bioscan Screening Systems
  • Branan Medical Corp
  • Concateno, Plc
  • Confirm Biosciences
  • Devon Medical Products
  • Elitech Group
  • Express Diagnostics International Inc.
  • Hoffmann-La Roche, Ltd.
  • Identa Corp
  • Lifeloc Technologies
  • Lifesign
  • Mavand Solutions
  • Medtest DX
  • Medtox Diagnostics
  • Microgenics
  • Mossman Associates
  • MP Biomedicals
  • Nano-Ditech Corp.
  • Orasure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • Prechek Bio
  • Princeton Biomeditech
  • Psychemedics
  • Randox Laboratories
  • Redwood Toxicology Laboratory
  • Roche Diagnostics
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • UCP Biosciences

List of Tables

Summary Table : Global DOA Testing Market Forecast, by Test Type, Through 2022
Table 1 : Advantages and Disadvantages of Point of Care Testing
Table 2 : Major Advantages and Disadvantages of Onsite Testing
Table 3 : Detection Periods for Various Types of Drug Testing
Table 4 : Common Parameters Tested for Urine Specimen Validity
Table 5 : Some of the Commercial/Common Adulterants Used in Fooling Urine Tests and Their Effects
Table 6 : Urine Sample Validity Test Methods
Table 7 : Cross Reactants That Can Lead to False Positives in DOA Testing
Table 8 : Clearance Rates for Common DOA
Table 9 : U.S. Drug Testing Legislations by State, 2017
Table 10 : Selected State Marijuana Legalization, 2016
Table 11 : Drug Testing Legislation by European Country
Table 12 : Number of Illicit Drug Users Globally, 2015
Table 13 : Number of Drug-Related Deaths, Mortality Rates per Million Persons Aged 15-64 Years and Ranking of Drugs as Primary Cause of Death (2014 or Latest Year Available), 2016
Table 14 : Estimated Number of Drug-Related Deaths and Mortality Rates per Million Persons Aged 15-64 Years, 2014
Table 15 : Annual Prevalence by Region, 2016
Table 16 : U.S. DOA Seizures, 2014
Table 17 : Annual Prevalence of Opioid Use as a Percentage of the Population Aged 15-64, 2015
Table 18 : Annual Prevalence of Cocaine Use as a Percentage of the Population Aged 15-64, 2015
Table 19 : Annual Prevalence of Cannabis Use as a Percentage of the Population Aged 15-64, 2015
Table 20 : Annual Prevalence of ATS Use as a Percentage of the Population Aged 15-64, 2015
Table 21 : Annual Prevalence of Ecstasy Use as a Percentage of the Population Aged 15-64, 2015
Table 22 : Drug Abuse Statistics in the U.S. by Drug Type (12 Yrs and Older), 2014 and 2015
Table 23 : U.S. Types of Illicit Drug Use in Lifetime, Past Year, and Past Month Among Persons Aged 18 or Older: Percentages, 2014 and 2015
Table 24 : U.S. Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2014 and 2015
Table 25 : U.S. Marijuana Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2014 and 2015
Table 26 : Global Sales Contribution for DOA Testing, by Sample Type, Through 2022
Table 27 : Global Sales Forecast for DOA Testing, by Sample Type, Through 2022
Table 28 : Global Sales Forecast for DOA Testing by Urine, Through 2022
Table 29 : Global Sales Forecast for DOA Testing by Urine: Laboratory-based versus Onsite, through 2022
Table 30 : Global Sales Forecast for DOA Testing, by Blood, Through 2022
Table 31 : Global Sales Forecast for DOA Testing, by Oral Fluid, Through 2022
Table 32 : Global Sales Forecast for DOA Testing by Oral Fluid: Laboratory-based versus Onsite, Through 2022
Table 33 : Global Sales Forecast for DOA Testing, by Hair, Through 2022
Table 34 : Global Sales Forecast for DOA Testing, by Sweat, Through 2022
Table 35 : Global Sales Forecast for DOA Testing, by Other Sample Types, Through 2022
Table 36 : Global DOA Testing Market Forecast, by Region, Through 2022
Table 37 : DOA Testing Market Forecast for Laboratory-based DOA Testing, Through 2022
Table 38 : DOA Testing Market Forecast for Onsite DOA Testing, Through 2022
Table 39 : Most Notable Mergers and Acquisitions in the DOA Testing Markets, 2000-2016
Table 40 : Major Companies and Their Products in the DOA Testing Market
Table 41 : Companies Offering Laboratory-based DOA Testing Products
Table 42 : Main Onsite DOA Testing Market Players and Their Products
Table 43 : Common DOA and Popular Urine Drug Screening Products
Table 44 : Key Market Players Offering DOA Testing Products on Oral Fluid, Hair and Sweat Sample Types
Table 45 : Selected U.S. Patents Granted for DOA Testing, 2007-2017

List of Figures

Summary Figure : Global Drugs of Abuse Testing Market Forecast, by Test Matrix, 2016-2022
Figure 1 : U.S. DOA Seizures, 2014
Figure 2 : Global Sales Forecast for DOA Testing, by Sample Type, 2016-2022
Figure 3 : Global Sales Forecast for Drugs of Abuse Testing by Urine, 2016-2022
Figure 4 : Global Sales Forecast for Drugs of Abuse Testing by Urine: Laboratory-based versus Onsite, 2016-2022
Figure 5 : Global Sales Forecast for Drugs of Abuse Testing, by Blood, 2016-2022
Figure 6 : Global Sales Forecast for Drugs of Abuse Testing, by Oral Fluid, 2016-2022
Figure 7 : Global Sales Forecast for Drugs of Abuse Testing, by Oral Fluid: Laboratory-based versus Onsite, 2016-2022
Figure 8 : Global Sales Forecast for Drugs of Abuse Testing, by Hair, 2016-2022
Figure 9 : Global Sales Forecast for Drugs of Abuse Testing by Sweat, 2016-2022
Figure 10 : Global Sales Forecast for DOA Testing, by Other Sample Types, 2016-2022
Figure 11 : Drugs of Abuse Testing Markets, by Geographic Region, 2017

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 1 Step Detect Associates
  • Alfa Scientific
  • Bioscan Screening Systems
  • Hoffmann-La Roche, Ltd.
  • Medtox Diagnostics
  • Polymed Therapeutics
  • MORE

Analyst Credentials:

Jon Evans has been involved in business development and research for the medical industry since 1984. Evans' career includes four years as a diagnostic systems sales representative and more than 15 years in market research and strategy analysis with Fortune 500 clients. He has developed expertise in assessing the unique business development challenges facing firms in the medical industry and designing strategies to optimize market performance. Mr. Evans received a B.S. in biology from Rutgers University in 1983, and an MBA in business analysis from San Francisco State University in 1989.

Note: Product cover images may vary from those shown
5 of 6
  • 1 Step Detect Associates
  • Abbott Diagnostics
  • Accutech
  • Acon Laboratories
  • Agilent Technologies
  • Alere
  • Alfa Scientific
  • American Bio Medica
  • Atlas Link Biotech
  • Beckman Coulter
  • Biophor Diagnostics
  • Bio-Rad Laboratories
  • Bioscan Screening Systems
  • Branan Medical Corp
  • Concateno, Plc
  • Confirm Biosciences
  • Devon Medical Products
  • Elitech Group
  • Express Diagnostics International Inc.
  • Hoffmann-La Roche, Ltd.
  • Identa Corp
  • Lifeloc Technologies
  • Lifesign
  • Mavand Solutions
  • Medtest DX
  • Medtox Diagnostics
  • Microgenics
  • Mossman Associates
  • MP Biomedicals
  • Nano-Ditech Corp.
  • Orasure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • Prechek Bio
  • Princeton Biomeditech
  • Psychemedics
  • Randox Laboratories
  • Redwood Toxicology Laboratory
  • Roche Diagnostics
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • UCP Biosciences
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll